Hepatitis: The Silent Liver Killer | Investor's Almanac

Hepatitis, a group of infectious diseases that affect the liver, has been a persistent global health threat for centuries. With over 300 million people living with chronic hepatitis, the disease has become a major cause of liver cancer and liver transplantation. The five main types of hepatitis - A, B, C, D, and E - are caused by different viruses, each with its own unique characteristics and transmission modes. Despite significant advances in medical research, hepatitis remains a highly debated topic, with controversies surrounding vaccination policies, treatment options, and the role of lifestyle factors in disease prevention. According to the World Health Organization (WHO), hepatitis B and C alone account for approximately 1.4 million deaths worldwide each year, with a significant proportion of cases going undiagnosed. As researchers continue to unravel the complexities of hepatitis, it is essential to address the social, economic, and cultural factors that contribute to the spread of the disease, particularly in low-income and marginalized communities, where access to healthcare and preventive measures is often limited.